Medtronic
stock was downgraded to Neutral from Get by analysts at Citi, who elevated issue about the company’s potential to deliver steady income expansion.
Medtronic
(ticker: MDT) posted its next-quarter earnings Tuesday. Revenue arrived in at $7.59 billion, while Wall Avenue analysts had predicted $7.7 billion.
